| | 
Part, Chapter, Paragraph
1 I, 3. 4 | States? Demography 21(4) pp. 591-611.~ ~Esveldt, I.,
2 II, 5. 5. 3| courses are lumped to RR or PP ones.~ ~Disability~Several
3 II, 5. 5. 3| Leuchtturm-Verlag/LTV Press, Darmstadt, pp 219-230.~Brønnum-Hansen
4 II, 5. 5. 3| Churchill Livingstone, 1998, pp 191-221.~Ebers GC (2008).
5 II, 5. 5. 3| Monduzzi Editore, Bologna, pp 253-255.~Koch-Henriksen
6 II, 5. 5. 3| Leuchtturm-Verlag/LTV Press, Darmstadt, pp 266-273.~Lublin FD, Rengold
7 II, 5. 5. 3| Leuchtturm-Verlag/LTV Press, Darmstadt, pp 113-121.~Modrego Pardo PJ,
8 II, 5. 6. 6| Lippincott-Raven Publishers, pp 225-47~Melton LJ, III (2003):
9 II, 5. 10. 7| European Union L 109, 6.5.2000, pp. 29–42.~htt ~ ~European
10 II, 5. 10. 7| Union L 308, 25.11.2003, pp. 15–18.~htt ~ ~European
11 II, 5. 10. 7| Union L 75, 22.03.2005, pp. 33–34.~htt ~ ~European
12 II, 5. 10. 7| Union L 310, 28.11.2007, pp. 11–14.~ ~European Food
13 II, 5. 10. 7| Thirty-seventh series, pp. 41.~ ~Stern M, Ciclitira
14 II, 5. 14. 8| Bourgeois D.M., Llodra JC., pp. 7-17. Quintessence Publishing
15 II, 8. 2. 1| VARIOUS EU-LEVEL ACTORS, pp 2-3. <www.eurohealthnet.
16 II, 9. 1. 2| The Lancet, Vol 369, pp 641-642.~Bianchi F, Bianca
17 II, 9. 1. 2| Research (Part A), Vol 76, pp 693-705.~Bréart G, Barros
18 II, 9. 1. 2| Toxicology, Vol 20, No 3, pp 393-402. ~Busby A, Abramsky
19 II, 9. 1. 2| Medical Journal, Vol 330, pp 574-575.~Busby A, Ritvanen
20 II, 9. 1. 2| Medical Journal, Vol 331, pp 140-41. ~Cordier S, Bergeret
21 II, 9. 1. 2| Epidemiology, Vol 8, No 4, pp 355-363.~Cordier S, Ha M-C,
22 II, 9. 1. 2| Environmental Health, Vol 18, pp 11-17.~De Walle HE, de Jong
23 II, 9. 1. 2| Sante Publique, Vol 53, pp 2S87-2S95.~Dolk H, Vrijheid,
24 II, 9. 1. 2| Perspectives, Vol 112, No 3, pp 398-402.~Dolk H, Vrijheid
25 II, 9. 1. 2| Medical Bulletin, Vol 68, pp 25-45.~EUROCAT (2007): Available
26 II, 9. 1. 2| Community Health, Vol 45, No 1, pp 52-58.~Garne E, Loane M,
27 II, 9. 1. 2| Congenital Heart Diseases, Vol 2, pp 165-169.~Garne E, Loane
28 II, 9. 1. 2| and Gynecology, Vol 25, pp 6-11.~Garne E, Loane M,
29 II, 9. 1. 2| Prenatal Diagnosis, Vol 24, pp 908-12.~Garne E et al (1999): "
30 II, 9. 1. 2| Neonatal Medicine, Vol 4, pp 441-447.~Green JM, Hewison
31 II, 9. 1. 2| Perinatal Epidemiology, Vol 21, pp 363-369.~Macintosh MCM,
32 II, 9. 1. 2| Arch Dis Childh, Vol 82, pp 349-352.~Waller K, Shaw
33 II, 9. 3. 1| Number 4, April 2005 , pp. 245-253(9)~ ~Gabriel P,
34 II, 9. 3. 1| Demographic Research 13(15), pp 363-388~ ~Haslam, D (2007)
35 II, 9. 3. 1| Policy. Helsinki (2006): 112 pp. (Publications of the Ministry
36 II, 9. 4. 7| Number 6, November 2004 , pp. 618-624(7)~Billings, J.
37 II, 9. 4. 7| Health Trends. vol. 25, pp. 31–37.~ ~International
38 II, 9. 4. 7| Number 4, December 2003 , pp. 173-174(2)~ ~Mukaetova-Ladinska
39 II, 9. 5. 6| schools. Sex Education, 3(1), pp. 47-59.~ ~Probyn E (2000):
40 II, 9. 5. 6| Body and Society, 6(1), pp. 13-28.~ ~Risberg G, Hamber
41 III, 10. 2. 1| percentage points per year (pp/y) based on measured data,
42 III, 10. 2. 1| were in Spain (1.2 and 0.9 pp/y in women and men respectively,
43 III, 10. 2. 1| Statistics, 2007), Ireland (1.1 pp/y for both sexes from 1998
44 III, 10. 2. 1| 2003), Denmark (0.9 and 0.7 pp/y, respectively, from 1987
45 III, 10. 2. 4| Oxford University Press, pp 17-37.~ ~French ME, Moore
46 III, 10. 4. 2| Dioxin-like PCBS” 28-29 June 2004. pp. 130. ISBN 29-9199-000-0~ ~
47 III, 10. 4. 2| forward”. 28-29 November 2006. pp. 157~ISBN: 978-92-9199-064-
48 III, 10. 4. 2| animals”. 1-2 December 2005.pp. 156. ISBN: 92-9199-030-
49 III, 10. 4. 2| feed. 13-14 December 2004. pp. 142. ISBN: 92-9199-012-
50 III, 10. 4. 2| carcinogenic. 16-18 November 2005. pp.286.~ ~Kallenborn R. (2006):
51 III, 10. 5. 1| Number 11, November 1998, pp. 1389-1396(8)~ ~European
52 III, 10. 5. 3| and Policy Implications (pp. 73-100). Oxford: Oxford
53 III, 10. 6. 2| Social Epidemiology (pp. 137-173). New York: Oxford
54 IV, 11. 6. 5| Krasnik A, Groenewegen PP et al. (1990): "Changing
|
|
| |
